Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012

por Padrnos, Leslie, Karlin, Nina, Halfdanarson, Thorvardur R.
Publicado 2016

Advances in systemic therapy for advanced pancreatobiliary malignancies

por Halfdanarson, Thorvardur R, Haraldsdottir, Sigurdis, Borad, Mitesh J
Publicado 2013

Pilot Study Characterizing the Hematology-Oncology Fellow Job Search Process: Tools Used and Identification of Potential New Resources

por Marshall, Ariela L., Halfdanarson, Thorvardur R., Alkhateeb, Hassan, Hobday, Timothy
Publicado 2021

Targeted Alpha-Particle Therapy: A Review of Current Trials

por Jang, Albert, Kendi, Ayse T., Johnson, Geoffrey B., Halfdanarson, Thorvardur R., Sartor, Oliver
Publicado 2023

Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective St...

por Diamantopoulos, Leonidas N., Kalligeros, Markos, Halfdanarson, Thorvardur R., Diamantis, Nikolaos, Toumpanakis, Christos
Publicado 2023

Constrictive bronchiolitis in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

por Samhouri, Bilal F., Azadeh, Natalya, Halfdanarson, Thorvardur R., Yi, Eunhee S., Ryu, Jay H.
Publicado 2020

Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States

por Shah, Shrunjal, Gosain, Rohit, Groman, Adrienne, Gosain, Rahul, Dasari, Arvind, Halfdanarson, Thorvardur R., Mukherjee, Sarbajit
Publicado 2021

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights

por Starr, Jason S, Sonbol, Mohamad Bassam, Hobday, Timothy J, Sharma, Akash, Kendi, Ayse Tuba, Halfdanarson, Thorvardur R
Publicado 2020

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy

por Halfdanarson, Thorvardur R., Mallak, Nadine, Paulson, Scott, Chandrasekharan, Chandrikha, Natwa, Mona, Kendi, Ayse Tuba, Kennecke, Hagen F.
Publicado 2023

Management of Diarrhea in Patients With Carcinoid Syndrome

por Naraev, Boris G., Halland, Magnus, Halperin, Daniel M., Purvis, Amy J., O'Dorisio, Thomas M., Halfdanarson, Thorvardur R.
Publicado 2019

Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm

por Haddox, C. L., Shenoy, N., Shah, K. K., Kao, J. C., Jain, S., Halfdanarson, T. R., Wijdicks, E. F., Goetz, M. P.
Publicado 2017

Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study

por Schroeder, Mary C., Chapman, Cole G., Nattinger, Matthew C., Halfdanarson, Thorvardur R., Abu-Hejleh, Taher, Tien, Yu-Yu, Brooks, John M.
Publicado 2016

N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma

por Halfdanarson, Thorvardur R, Foster, Nathan R, Kim, George P, Haddock, Michael G, Dakhil, Shaker R, Behrens, Robert J, Alberts, Steven R
Publicado 2022

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas

por Smaglo, Brandon G., Tesfaye, Anteneh, Halfdanarson, Thorvardur R., Meyer, Joshua E., Wang, Jue, Gatalica, Zoran, Reddy, Sandeep, Arguello, David, Boland, Patrick M.
Publicado 2015

Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis

por Sonbol, Mohamad Bassam, Mazza, Gina L, Mi, Lanyu, Oliver, Thomas, Starr, Jason, Gudmundsdottir, Hallbera, Cleary, Sean P, Hobday, Timothy, Halfdanarson, Thorvardur R
Publicado 2022

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Cent...

por Halfdanarson, Thorvardur R., Foster, Nathan R., Kim, George P., Meyers, Jeffrey P., Smyrk, Thomas C., McCullough, Ann E., Ames, Matthew M., Jaffe, Jeffrry P., Alberts, Steven R.
Publicado 2019

Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab

por Saberzadeh-Ardestani, Bahar, Jones, Jeremy C., Hubbard, Joleen M., McWilliams, Robert R., Halfdanarson, Thorvardur R., Shi, Qian, Sonbol, Mohamad Bassam, Ticku, Jonathan, Jin, Zhaohui, Sinicrope, Frank A.
Publicado 2023

Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases

por Venable, Elise R., Kerr, Sarah E., Lopes, M. Beatriz S., Jones, Karra A., Bellizzi, Andrew M., Mounajjed, Taofic, Raghunathan, Aditya, Hamidi, Oksana, Halfdanarson, Thorvardur R., Ryder, Mabel, Graham, Rondell P.
Publicado 2020

Hepatoid Carcinoma of the Pancreas: Case Report, Next-Generation Tumor Profiling, and Literature Review

por Chang, James M., Katariya, Nitin N., Lam-Himlin, Dora M., Haakinson, Danielle J., Ramanathan, Ramesh K., Halfdanarson, Thorvardur R., Borad, Mitesh J., Pannala, Rahul, Faigel, Douglas, Moss, Adyr A., Mathur, Amit K.
Publicado 2016

Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review...

por Yang, Fang, Markovic, Svetomir N., Molina, Julian R., Halfdanarson, Thorvardur R., Pagliaro, Lance C., Chintakuntlawar, Ashish V., Li, Rutian, Wei, Jia, Wang, Lifeng, Liu, Baorui, Nowakowski, Grzegorz S., Wang, Michael L., Wang, Yucai
Publicado 2020